Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of 2.28x is 464% above its 2-year average of -0.63x, around the middle of its 2-year range (-7.50x–7.20x).
1.50% above its 12-month average of 2.25x.
Reported quarterly interest coverage; no daily interpolation. Q2 FY2026 (2026-06-30): -0.08x.
INTEREST COVERAGE RATIO
2.28x
INTEREST COVERAGE RATIO AVG TTM
2.25x
INTEREST COVERAGE RATIO AVG 3Y
-0.63x
INTEREST COVERAGE RATIO AVG 5Y
-0.63x
INTEREST COVERAGE RATIO AVG 10Y
-0.63x
INTEREST COVERAGE RATIO AVG 15Y
-0.72x
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+1.50%
CURRENT VS 3Y AVG
+463.62%
CURRENT VS 5Y AVG
+463.62%
CURRENT VS 10Y AVG
+463.62%
CURRENT VS 15Y AVG
+414.73%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-6.38x
median of 528 covered companies
CURRENT VS SECTOR MEDIAN
+135.76%
vs the sector median at left
OptimizeRx Corp.
Market Cap
$165.70M
Interest Coverage Ratio
2.28x
TTM Avg
2.25x
3Y Avg
-0.63x
5Y Avg
-0.63x
Market Cap
$163.22M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$163.00M
Interest Coverage Ratio
-19.95x
TTM Avg
6.75x
3Y Avg
6.75x
5Y Avg
6.75x
Market Cap
$169.17M
Interest Coverage Ratio
-38.13x
TTM Avg
21.71x
3Y Avg
21.71x
5Y Avg
21.71x
Market Cap
$169.85M
Interest Coverage Ratio
N/A
TTM Avg
8.41x
3Y Avg
7.29x
5Y Avg
7.29x
Market Cap
$170.21M
Interest Coverage Ratio
-74.29x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$160.11M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| OptimizeRx Corp. (OPRX) | $165.70M | 2.28x | 2.25x | -0.63x | -0.63x |
| Nkarta, Inc. (NKTX)vs › | $167.67M | N/A | N/A | N/A | N/A |
| Quanterix Corporation (QTRX)vs › | $163.22M | N/A | N/A | N/A | N/A |
| Coherus Oncology, Inc. (CHRS)vs › | $163.00M | -19.95x | 6.75x | 6.75x | 6.75x |
| MediWound Ltd. (MDWD)vs › | $169.17M | -38.13x | 21.71x | 21.71x | 21.71x |
| Organogenesis Holdings Inc. (ORGO)vs › | $169.85M | N/A | 8.41x | 7.29x | 7.29x |
| Cue Biopharma, Inc. (CUE)vs › | $170.21M | -74.29x | N/A | N/A | N/A |
| PepGen Inc. (PEPG)vs › | $160.82M | N/A | N/A | N/A | N/A |
| Minerva Neurosciences, Inc. (NERV)vs › | $160.11M | N/A | N/A | N/A | N/A |
| Precision BioSciences, Inc. (DTIL)vs › | $171.41M | -36.67x | N/A | N/A | N/A |
Interest Coverage
2.3x
Debt/Equity
0.15
Current Ratio
5.58
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-06-30 | -0.08x |
| 2026-03-31 | 0.34x |
| 2025-12-31 | 7.20x |
| 2025-09-30 | 1.78x |
| 2025-06-30 | 1.99x |
| 2025-03-31 | -1.63x |
| 2024-12-31 | 2.33x |
| 2024-09-30 | -5.62x |
| 2024-06-30 | -2.45x |
| 2024-03-31 | -3.25x |
| 2023-12-31 | -7.50x |
| 2016-03-31 | -2219.81x |
| 2012-09-30 | -1061.51x |
| 2011-09-30 | -0.43x |
| 2011-06-30 | -2.09x |
| 2011-03-31 | -0.54x |
| 2010-12-31 | -1.92x |
| 2010-06-30 | -5305.23x |
| 2010-03-31 | -4291.98x |
| 2009-12-31 | -5863.52x |
| 2009-09-30 | -756.32x |
| 2009-06-30 | -17600.65x |
| 2009-03-31 | -5522.22x |
| 2008-12-31 | -1535.33x |
